WNT3A, Wnt family member 3A, 89780

N. diseases: 141; N. variants: 5
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.010 Biomarker disease BEFREE WISP-2 was upregulated in human atherosclerosis and partly co-localized with Wnt3a. 30548452 2019
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.010 Biomarker disease BEFREE WISP-2 was upregulated in human atherosclerosis and partly co-localized with Wnt3a. 30548452 2019
CUI: C0004238
Disease: Atrial Fibrillation
Atrial Fibrillation
0.010 Biomarker disease BEFREE Our results provide a new evidence that miR-27b-3p regulates the signaling pathway of Wnt/<i>β</i>-Catenin by targeting Wnt3a, which may play an important role in the development of atrial fibrosis and AF. 31178968 2019
Malignant neoplasm of urinary bladder
0.010 Biomarker disease BEFREE In summary, our findings demonstrated that LINC00536 promoted BC progression by modulating the Wnt3a/β-Catenin signaling. 30851243 2019
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.010 Biomarker disease BEFREE In summary, our findings demonstrated that LINC00536 promoted BC progression by modulating the Wnt3a/β-Catenin signaling. 30851243 2019
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.010 GeneticVariation disease BEFREE This case-control study evaluated the association of SNPs in IRF6 (rs642961), WNT3A (rs708111), GSK3β (rs9879992), 8q24 (rs987525) and WNT11 (rs1533767), representing regions consistently identified as of susceptibility for oral clefts, with oral cancer (oral squamous cell carcinoma) and breast cancer. 30579133 2019
CUI: C0023418
Disease: leukemia
leukemia
0.010 Biomarker disease BEFREE This review summarizes the role of Wnt3a in the pathogenesis of different cancers including colorectal, prostate, hepatocellular, lung and leukemia, for promoting greater understanding and clinical management of these diseases. 31236761 2019
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.010 Biomarker disease BEFREE The TPSi NP with a pore size of 10.7 nm and inorganic framework enables high-efficiency loading of Wnt3a, prolongs Wnt3a release, and increases antioxidative stress activity in the labeled mesenchymal stem cells (MSCs), which are highly beneficial properties for cell protection in stem cell therapy for myocardial infarction. 30488562 2019
CUI: C0030193
Disease: Pain
Pain
0.010 AlteredExpression phenotype BEFREE These findings collectively suggest that HIV-1 gp120 induces synaptic degeneration in the spinal pain neural circuit by activating microglia via Wnt3a/β-catenin-regulated FKN expression in neurons.<b>SIGNIFICANCE STATEMENT</b> Synaptic degeneration develops in the spinal cord dorsal horn of HIV patients with chronic pain, but the patients without the pain disorder do not show this neuropathology, indicating a pathogenic contribution of the synaptic degeneration to the development of HIV-associated pain. 31471472 2019
CUI: C0031030
Disease: Periapical Periodontitis
Periapical Periodontitis
0.010 GeneticVariation disease BEFREE Haplotypes involving WNT3-WNT9B-WNT3A alleles were also significantly associated with AP (P ≤ 0.003). 31831777 2019
CUI: C0035335
Disease: Retinoblastoma
Retinoblastoma
0.010 AlteredExpression disease BEFREE Wnt3a was upregulated in human RB tissues, and its upregulation was inversely associated with miR‑485. 30896857 2019
CUI: C0041341
Disease: Tuberous Sclerosis
Tuberous Sclerosis
0.010 Biomarker disease BEFREE In this study, we used bovine fetal fibroblasts and added Wnt3a to the 2i medium to establish another bovine TSC line (BTSW). 30896984 2019
CUI: C0149978
Disease: Adenocarcinoma of rectum
Adenocarcinoma of rectum
0.010 AlteredExpression disease BEFREE TIPE2 overexpression increased apoptosis through down-regulating the expression levels of Wnt3a, phospho (p)-β-Catenin, and p-glycogen synthase kinase-3β in rectal adenocarcinoma cells, however, TIPE2 knockdown exhibited reverse trends. 30637920 2019
CUI: C0153381
Disease: Malignant neoplasm of mouth
Malignant neoplasm of mouth
0.010 GeneticVariation group BEFREE This case-control study evaluated the association of SNPs in IRF6 (rs642961), WNT3A (rs708111), GSK3β (rs9879992), 8q24 (rs987525) and WNT11 (rs1533767), representing regions consistently identified as of susceptibility for oral clefts, with oral cancer (oral squamous cell carcinoma) and breast cancer. 30579133 2019
CUI: C0220641
Disease: Lip and Oral Cavity Carcinoma
Lip and Oral Cavity Carcinoma
0.010 GeneticVariation disease BEFREE This case-control study evaluated the association of SNPs in IRF6 (rs642961), WNT3A (rs708111), GSK3β (rs9879992), 8q24 (rs987525) and WNT11 (rs1533767), representing regions consistently identified as of susceptibility for oral clefts, with oral cancer (oral squamous cell carcinoma) and breast cancer. 30579133 2019
CUI: C0280324
Disease: Laryngeal Squamous Cell Carcinoma
Laryngeal Squamous Cell Carcinoma
0.010 Biomarker disease BEFREE The current findings suggest that Wnt3a is tightly related to the LSCC progression and could serve as a valuable clinic biomarker for LSCC patients. 31528227 2019
Secondary malignant neoplasm of lymph node
0.010 AlteredExpression disease BEFREE When stratified survival analyses were performed, patients with lymph node metastasis/advanced clinical stages and high Wnt3a expression had worse OS rates than patients with other features (P < 0.001). 31528227 2019
CUI: C0699885
Disease: Carcinoma of bladder
Carcinoma of bladder
0.010 Biomarker disease BEFREE In summary, our findings demonstrated that LINC00536 promoted BC progression by modulating the Wnt3a/β-Catenin signaling. 30851243 2019
CUI: C0740394
Disease: Hyperuricemia
Hyperuricemia
0.010 AlteredExpression disease BEFREE In this study, the levels of Wnt3a and differentiation-related factors, including Runx2, Sp7, Ibsp, Bglap, Dmp1, and Col1a1, were all evidently decreased in HUC rats, while the presence of ALLO increased the levels of above factors. 31407397 2019
Squamous cell carcinoma of the head and neck
0.010 AlteredExpression disease BEFREE Finally, expression of the Wnt3a protein was elevated in both SCCHN tissues and patients' serum. 31111621 2019
CUI: C1328504
Disease: Hormone refractory prostate cancer
Hormone refractory prostate cancer
0.010 Biomarker disease BEFREE However, the biological function and mechanisms of PLCε and wnt3a in CRPC remain unknown. 30684266 2019
CUI: C1332977
Disease: Childhood Leukemia
Childhood Leukemia
0.010 Biomarker disease BEFREE This review summarizes the role of Wnt3a in the pathogenesis of different cancers including colorectal, prostate, hepatocellular, lung and leukemia, for promoting greater understanding and clinical management of these diseases. 31236761 2019
CUI: C1512409
Disease: Hepatocarcinogenesis
Hepatocarcinogenesis
0.010 AlteredExpression disease BEFREE Dynamic alterations of Wnt3a levels were detected in the hepatocarcinogenesis model induced by 2-acetylaminofluorene. 31737122 2019
CUI: C0000768
Disease: Congenital Abnormality
Congenital Abnormality
0.010 AlteredExpression group BEFREE It is worth noting that neurons in the ventricular zone, especially motor neurons, could not migrate laterally after the Wnt3a overexpression, which led to the malformation of motor column. 29574664 2018
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.010 AlteredExpression disease BEFREE Repression of miR-145 expression by Ang II resulted in increased Dab2 and decreased Wnt3a and ß-catenin expression under hyperglycaemia. 29178342 2018